COMPLIANCE INFO_PRE 2019 - Laserfiche WebLink

Home Browse Search

t t � I Code section 25504,subdivisions(a)and(c),and California Code of Regulations,Title 19,section 2 2732. 3 4.1.1. Defendant shall comply with all employee training obligations required by 4 California Code of Regulations,Title 22,section 66265.16,pertaining to the handling of hazardous 5 waste, including,but not limited to,the requirement to maintain for a period of three(3)years,all 6 training documentation for each employee involved in hazardous waste handling at any Facility. 7 4.Lin. Defendant shall properly manage,mark,and store universal waste,as provided by 8 Title 22 of the California Code of Regulations sections 66273.13-66273.16(repealer filed 2-4-2009) 9 and sections 66273.33 -66273.36. 10 4.1.n. Defendant shall keep a record with the information required by section 66273.39, 11 subdivisions(a)(1)-(3),of each shipment of universal waste received at any Facility,as provided by 12 Title 22 of the California Code of Regulations section 66273.39. Such records may be stored 13 electronically. 14 4.1.o. Defendant shall comply with the California Medical Waste Management Act,Health 15 and Safety Code sections 117600,et seq. 16 4.2. Reverse Distribution of Pharmaceuticals: 17 4.2.a. By August 1,2012,Defendant shall initiate work with appropriate stakeholders from 18 business and government,including the U.S.Environmental Protection Agency,the U.S.Food and 19 Drug Administration,and the DTSC,and thereafter either directly or through trade associations or 20 informal coalitions of interested parties,undertake to promote federal regulatory reform regarding the 21 proper management of nondispensable pharmaceuticals,including over-the-counter medications, 22 through Reverse Distribution. Such work shall include coordination and communication with 23 national retail trade associations. Progress on such work shall be included in the status reports 24 required by Paragraph 23 below. 25 4.2.b. During the term of this Final Judgment,the People shall only pursue a violation of this 26 Final Judgment or applicable law regarding the Reverse Distribution of such nondispensable 27 pharmaceuticals if Defendant has failed to demonstrate reasonable diligence in performing work on 28 the federal regulatory reform described in subparagraph 4.2.a.above,and provided further,nothing 6 sf-3138122 Stipulation for Entry of Final Judgment and Permanent Injunction